In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells ; volume:9 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-9 ; date:12.2019
Scientific reports ; 9, Heft 1 (7.2.2019), 1-9, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Gravett, Andrew M.
Dalgleish, Angus G.
Copier, John
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-38190-2
- URN
-
urn:nbn:de:101:1-2019030820111063315729
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gravett, Andrew M.
- Dalgleish, Angus G.
- Copier, John
- SpringerLink (Online service)
Other Objects (12)
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
The NKG2D ligand ULBP4 is not expressed by human monocytes
The NKG2D ligand ULBP4 is not expressed by human monocytes
Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma
NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes
Deciphering the transcription factors that regulate the NKG2D ligand MICA in cancer cells
Inhibition of UBA6 by inosine augments tumour immunogenicity and responses
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype
Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway
Expression and function of the paradigmatic human NKG2D ligand MICA in a transgenic mouse model
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
The NKG2D ligand ULBP4 is not expressed by human monocytes
The NKG2D ligand ULBP4 is not expressed by human monocytes
Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma
NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes
Deciphering the transcription factors that regulate the NKG2D ligand MICA in cancer cells
Inhibition of UBA6 by inosine augments tumour immunogenicity and responses
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype
Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway
Expression and function of the paradigmatic human NKG2D ligand MICA in a transgenic mouse model
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
The NKG2D ligand ULBP4 is not expressed by human monocytes
The NKG2D ligand ULBP4 is not expressed by human monocytes
Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma
NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes
Deciphering the transcription factors that regulate the NKG2D ligand MICA in cancer cells
Inhibition of UBA6 by inosine augments tumour immunogenicity and responses
Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype
Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway